eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. (EFTR) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 151 transactions totaling $6.1M, demonstrating a bearish sentiment with -$5.7M in net insider flow. The most recent transaction on May 15, 2024 involved a transaction of 1,806 shares valued at $3.0K.
EFTR Insider Activity Summary
Who Is Buying EFTR Stock?
No significant insider buying has been recorded for EFTR in the recent period.
Who Is Selling EFTR Stock?
No significant insider selling has been recorded for EFTR in the recent period.
Is eFFECTOR Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EFTR is bearish with an Insider Alignment Score of 3/100 and a net flow of -$5.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
EFTR Frequently Asked Questions
Understanding EFTR Insider Activity
Insider trading at eFFECTOR Therapeutics, Inc. (EFTR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading EFTR stock, having executed 151 transactions in the past 90 days. The most active insider is Jonathan D. Root (Executive), who has made 44 transactions totaling $9.7M.
Related Tools
Track eFFECTOR Therapeutics, Inc. Insider Activity
Get notified when executives and directors at EFTR file new Form 4 transactions